These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34156682)

  • 1. Utility of the DECAF score for predicting survival of patients with COPD: a meta-analysis of diagnostic accuracy studies.
    Shen MH; Qiu GQ; Wu XM; Dong MJ
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4037-4050. PubMed ID: 34156682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin (PCT) Improves the Accuracy and Sensitivity of Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation (DECAF) Score in Predicting AECOPD Patients Admission to ICU.
    Chen Y; Li LIQ; Ge YL; Hu XY; Zhang Q; Zhang HF; Li WQ; Zhang S; Zhu XY; Zhang JB
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Huang Q; He C; Xiong H; Shuai T; Zhang C; Zhang M; Wang Y; Zhu L; Lu J; Jian L
    BMJ Open; 2020 Oct; 10(10):e037923. PubMed ID: 33127631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The v-DECAF score can predict 90-day all-cause mortality in patients with COPD exacerbation requiring invasive mechanical ventilation.
    Shi QF; Sheng Y; Zhu N; Tan Y; Xie XH; Wang SY; Cai JF
    Clin Respir J; 2019 Jul; 13(7):438-445. PubMed ID: 30955228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the DECAF Score in Predicting In-hospital Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Memon MA; Faryal S; Brohi N; Kumar B
    Cureus; 2019 Jun; 11(6):e4826. PubMed ID: 31403014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease.
    Steer J; Gibson J; Bourke SC
    Thorax; 2012 Nov; 67(11):970-6. PubMed ID: 22895999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An International Validation of the "DECAF Score" to Predict Disease Severity and Hospital Mortality in Acute Exacerbation of COPD in the UAE.
    Almarshoodi K; Echevarria C; Kassem A; Mahboub B; Salameh L; Ward C
    Hosp Pharm; 2024 Apr; 59(2):234-240. PubMed ID: 38450352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing severity scores in exacerbations of chronic obstructive pulmonary disease.
    Shafuddin E; Chang CL; Hancox RJ
    Clin Respir J; 2018 Dec; 12(12):2668-2675. PubMed ID: 30471191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of mortality in acute exacerbations of chronic obstructive pulmonary disease using the dyspnea, eosinopenia, consolidation, acidemia and atrial fibrillation score.
    Bansal AG; Gaude GS
    Lung India; 2020; 37(1):19-23. PubMed ID: 31898616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score.
    Echevarria C; Steer J; Bourke SC
    Thorax; 2019 Oct; 74(10):941-946. PubMed ID: 31387892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pooled analysis of the risk prediction models for mortality in acute exacerbation of chronic obstructive pulmonary disease.
    Ji Z; Li X; Lei S; Xu J; Xie Y
    Clin Respir J; 2023 Aug; 17(8):707-718. PubMed ID: 36945821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD.
    Echevarria C; Steer J; Heslop-Marshall K; Stenton SC; Hickey PM; Hughes R; Wijesinghe M; Harrison RN; Steen N; Simpson AJ; Gibson GJ; Bourke SC
    Thorax; 2016 Feb; 71(2):133-40. PubMed ID: 26769015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two scores for short-term outcomes in patients with COPD exacerbation in the emergency department: the Ottawa COPD Risk Scale and the DECAF score.
    Unal A; Bayram B; Ergan B; Can K; Ergun YK; Kilinc O
    ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 36923568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DECAF versus CURB-65 to Foresee Mortality among Patients Presenting with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Ahmed N; Jawad N; Jafri S; Raja W
    Cureus; 2020 Jan; 12(1):e6613. PubMed ID: 32064193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens.
    Kawamatawong T; Apiwattanaporn A; Siricharoonwong W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1625-1630. PubMed ID: 28615935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of risk scores in patients with acute exacerbations of COPD.
    Gomes L; Pereira S; Sousa-Pinto B; Rodrigues C
    J Bras Pneumol; 2023; 49(5):e20230032. PubMed ID: 37909549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation Score and BAP-65 Score, Tools for Prediction of Mortality in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Comparative Pilot Study.
    Sangwan V; Chaudhry D; Malik R
    Indian J Crit Care Med; 2017 Oct; 21(10):671-677. PubMed ID: 29142379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of DECAF (dysponea, eosinopenia, consolidation, acidaemia, and atrial fibrillation) and APACHE II (acute physiology and chronic health evaluation ii) scoring system to predict mortality among patients with acute exacerbation of chronic obstructive pulmonary disease.
    Raja W; Ahmed N; Rizvi NA; Vallacha A; Kumar D
    J Pak Med Assoc; 2021 Aug; 71(8):1935-1939. PubMed ID: 34418004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Frailty Assessment Tool to Predict In-Hospital Mortality in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Gu JJ; Liu Q; Zheng LJ
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1093-1100. PubMed ID: 33907395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR.
    Gayaf M; Karadeniz G; Güldaval F; Polat G; Türk M
    Expert Rev Respir Med; 2021 Jun; 15(6):845-851. PubMed ID: 33691562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.